Dharmacon OTP mouse druggable set of 4, 0.1 NM

Ended Purchase Order Awarded Last action

Contract number
75N95020P00376
Awardee
Awarding agency
Obligated
$92,029

Award facts

Opportunity
Contract value 100% obligated
$92,029.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lafayette, CO 80026, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Dharmacon, Inc., a foreign-owned for-profit company, for the delivery of DHARMACON OTP MOUSE DRUGGABLE SET OF 4, 0.1 NM. The contract was set aside for small businesses, with a ceiling value of $92,029.00 and a completion date of August 10, 2020. The contract originated from a solicitation for custom RNA interference (RNAi) small interfering RNA (siRNA) plates to support high-throughput screening and follow-up research conducted by NCATS' Functional Genomics Lab. Dharmacon has previously received multiple federal contract awards from NCATS and the National Institute on Drug Abuse to provide scientific research products and services, including CRISPR libraries, siRNA reagents, and other gene editing and drug discovery tools.

Quick answers

Who was awarded contract 75N95020P00376?

75N95020P00376 was awarded to Dharmacon, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 31, 2020.

How much is contract 75N95020P00376 worth?

The government has obligated $92,029 on 75N95020P00376.

Which agency awarded contract 75N95020P00376?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00376, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95020P00376 competed?

The extent of competition for 75N95020P00376 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award